EA199700354A1 - Способ лечения бактериальных инфекций, фармацевтическая лекарственная форма, содержащая амоксициллин и клавулановую кислоту - Google Patents

Способ лечения бактериальных инфекций, фармацевтическая лекарственная форма, содержащая амоксициллин и клавулановую кислоту

Info

Publication number
EA199700354A1
EA199700354A1 EA199700354A EA199700354A EA199700354A1 EA 199700354 A1 EA199700354 A1 EA 199700354A1 EA 199700354 A EA199700354 A EA 199700354A EA 199700354 A EA199700354 A EA 199700354A EA 199700354 A1 EA199700354 A1 EA 199700354A1
Authority
EA
Eurasian Patent Office
Prior art keywords
amoxycillin
composition
clavulanic acid
suspension
treating
Prior art date
Application number
EA199700354A
Other languages
English (en)
Other versions
EA001878B1 (ru
Inventor
Ричард Перегрин Бэкс
Майк Гейл Рэмси
Original Assignee
Смитклайн Бичам Плс
Смитклайн Бичам Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199700354(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9508989.2A external-priority patent/GB9508989D0/en
Priority claimed from GBGB9523655.0A external-priority patent/GB9523655D0/en
Application filed by Смитклайн Бичам Плс, Смитклайн Бичам Корпорейшн filed Critical Смитклайн Бичам Плс
Publication of EA199700354A1 publication Critical patent/EA199700354A1/ru
Publication of EA001878B1 publication Critical patent/EA001878B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Предложены педиатрические жидкие водные готовые формы в виде суспензий, содержащие тригидрат амоксициллина и клавуланат калия в соотношении от 6:1 до 8:1, для применения при лечении бактериальной инфекции при схеме приема дважды в день.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199700354A 1995-05-03 1996-05-02 Способ лечения бактериальных инфекций у детей EA001878B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508989.2A GB9508989D0 (en) 1995-05-03 1995-05-03 Pharmaceutical formulations
GBGB9523655.0A GB9523655D0 (en) 1995-11-18 1995-11-18 Method of treatment
PCT/EP1996/001881 WO1996034605A1 (en) 1995-05-03 1996-05-02 Composition comprising amoxycillin and clavulanic acid

Publications (2)

Publication Number Publication Date
EA199700354A1 true EA199700354A1 (ru) 1998-04-30
EA001878B1 EA001878B1 (ru) 2001-10-22

Family

ID=26306975

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700354A EA001878B1 (ru) 1995-05-03 1996-05-02 Способ лечения бактериальных инфекций у детей

Country Status (33)

Country Link
EP (2) EP1013274A3 (ru)
JP (1) JP3480939B2 (ru)
KR (2) KR19990008253A (ru)
CN (1) CN1104240C (ru)
AP (1) AP851A (ru)
AR (1) AR002993A1 (ru)
AT (2) ATE206051T1 (ru)
AU (1) AU712269C (ru)
BG (2) BG64270B1 (ru)
BR (1) BR9608270A (ru)
CZ (1) CZ294434B6 (ru)
DE (1) DE69615551T2 (ru)
DK (1) DK0825860T3 (ru)
DZ (1) DZ2028A1 (ru)
EA (1) EA001878B1 (ru)
ES (1) ES2160821T3 (ru)
GR (1) GR3036722T3 (ru)
HK (1) HK1009101A1 (ru)
HU (2) HU0201920D0 (ru)
IL (1) IL118091A (ru)
MA (1) MA24339A1 (ru)
MY (1) MY127622A (ru)
NO (1) NO975037D0 (ru)
NZ (1) NZ308478A (ru)
OA (1) OA10533A (ru)
PE (1) PE20011100A1 (ru)
PL (1) PL323103A1 (ru)
PT (1) PT825860E (ru)
RO (1) RO116343B1 (ru)
SK (1) SK283794B6 (ru)
TR (1) TR199701294T1 (ru)
UA (1) UA46763C2 (ru)
WO (1) WO1996034605A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1289084C (zh) 1995-09-07 2006-12-13 史密丝克莱恩比彻姆有限公司 药物制剂
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
GB9815532D0 (en) * 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
CN100391456C (zh) * 2005-04-30 2008-06-04 南京师范大学 β-环糊精/阿莫西林包合物及其与克拉维酸钾的组合物及制备方法
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN101406450B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方阿莫西林油混悬注射液制备工艺
KR20140117523A (ko) * 2012-01-10 2014-10-07 마이클 스펙터 아목시실린 및 클라불란산 칼륨의 소아용 경구 현탁 제형 및 이를 사용하기 위한 방법
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
CN106474122B (zh) * 2016-09-07 2020-04-14 湘北威尔曼制药股份有限公司 一种阿莫西林克拉维酸钾的药物组合物及其应用
CN108403676B (zh) * 2018-03-20 2020-08-21 中山大学 琥珀酸在提高细菌对抗生素敏感性方面的应用
CN116327760A (zh) * 2022-12-26 2023-06-27 南京臣功制药股份有限公司 一种阿莫西林克拉维酸钾缓释干混悬剂及其制备方法
CN117379378A (zh) * 2023-12-07 2024-01-12 山东金瑞生物科技有限公司 一种兽用复方阿莫西林可溶性粉及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
US4337887A (en) 1979-09-18 1982-07-06 Weyerhaeuser Company Reinforced half slotted container
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
OA10533A (en) 2002-04-29
GR3036722T3 (en) 2001-12-31
HUP9801064A3 (en) 1998-11-30
EP0825860B1 (en) 2001-09-26
NZ308478A (en) 1999-04-29
BG106763A (en) 2004-05-31
CN1189100A (zh) 1998-07-29
EA001878B1 (ru) 2001-10-22
RO116343B1 (ro) 2001-01-30
EP0825860A1 (en) 1998-03-04
BG64270B1 (bg) 2004-08-31
BG102024A (en) 1998-07-31
HK1009101A1 (en) 1999-05-28
WO1996034605A1 (en) 1996-11-07
AR002993A1 (es) 1998-05-27
CZ345997A3 (cs) 1998-03-18
UA46763C2 (uk) 2002-06-17
PL323103A1 (en) 1998-03-16
AU712269C (en) 2002-06-06
DE69615551D1 (de) 2001-10-31
AP851A (en) 2000-06-15
BG64271B1 (bg) 2004-08-31
ES2160821T3 (es) 2001-11-16
HUP9801064A2 (hu) 1998-08-28
TR199701294T1 (xx) 1998-04-21
AU712269B2 (en) 1999-11-04
AT4423U1 (de) 2001-07-25
EP1013274A2 (en) 2000-06-28
DZ2028A1 (fr) 2002-10-23
EP1013274A3 (en) 2000-07-05
PT825860E (pt) 2002-01-30
MY127622A (en) 2006-12-29
PE20011100A1 (es) 2002-01-06
JPH11504911A (ja) 1999-05-11
CZ294434B6 (cs) 2005-01-12
KR20050084498A (ko) 2005-08-26
AP9701122A0 (en) 1997-10-31
CN1104240C (zh) 2003-04-02
SK146297A3 (en) 1998-05-06
IL118091A0 (en) 1996-09-12
NO975037L (no) 1997-10-31
ATE206051T1 (de) 2001-10-15
NO975037D0 (no) 1997-10-31
JP3480939B2 (ja) 2003-12-22
MA24339A1 (fr) 1998-07-01
SK283794B6 (sk) 2004-01-08
KR19990008253A (ko) 1999-01-25
AU5814096A (en) 1996-11-21
DE69615551T2 (de) 2002-04-25
HU0201920D0 (ru) 2002-08-28
DK0825860T3 (da) 2001-11-19
IL118091A (en) 2004-07-25
BR9608270A (pt) 1999-05-04

Similar Documents

Publication Publication Date Title
EA199700354A1 (ru) Способ лечения бактериальных инфекций, фармацевтическая лекарственная форма, содержащая амоксициллин и клавулановую кислоту
EA199900647A1 (ru) Фармацевтический препарат, включающий в себя амоксициллин и клавуланат
EA200101075A1 (ru) Новый способ лечения
BR1100622A (pt) Processo anti-cd20 quimérico imunologicamenteativo, e, composição farmacêutica
AP9600868A0 (en) Polymer coated tablet comprising amoxycillin and clavulanate.
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
EP0303915A3 (en) Retinoids for the treatment of skin damaged by light
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
IE782130L (en) Imidazolidinones
CA2185119A1 (en) Dosage form for administering drug in liquid formulation
DE68910377T2 (de) Kosmetisches Präparat.
ID15895A (id) Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi
IT1264856B1 (it) Composizione farmaceutica ad attivita' analgesica
PT727996E (pt) Formulacoes de febbendazol
EP0848948A4 (en) COMPOSITION FOR LONG-TERM ACTION RECTAL ADMINISTRATION
RU95101041A (ru) Липосомные растворы
ES8206530A1 (es) Un procedimiento para la preparacion de 1,1,1',1'-tetraoxidode penicilanato de penicilanoiloximetilo
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
AU6922891A (en) Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
AU7614391A (en) Substituted indoles
HU911922D0 (en) New medical preparations containing 3,7-diazabicyclo(3.3.1)nonane compounds
MX9708383A (es) Composicion que comprende amoxicilina y acido clavulanico.
ECSP961736A (es) Metodo de tratamiento
KR930700100A (ko) 수의학적 치료
CA2079328A1 (en) Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof

Legal Events

Date Code Title Description
MK4A Patent expired

Designated state(s): AM AZ BY KZ KG MD TJ TM RU